FiBreath is developing next-generation inhalation technology to revolutionize how drugs are delivered to the lungs.
Backed by leading scientists and based in Israel, we are currently operating in stealth mode.
Our goal: make respiratory treatments safer, faster, and more effective - for millions of patients worldwide.
Company Details
- Employees
- 2
- Founded
- 2025
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Inhalation Therapy, Respiratory Drug Delivery, Medical Devices, Pulmonary Medicine, COPD Treatment, Asthma Treatment, Pharmaceutical Innovation, Advanced Drug Delivery Systems, Biotech, Inhaler Technology, Respiratory Care, HealthTech, Precision Medicine, Stealth Mode Startup, MedTech Startup.
Fibreath Questions
Fibreath's LinkedIn profile is https://www.linkedin.com/company/fibreath
Fibreath has
2 employees.
View email and phone details for 2
employees at Fibreath.
Fibreath's industry is
Pharmaceutical Manufacturing
Fibreath's top competitors are
Nanotherma,
Coralogix,
C For Success,
Femme Medical Ltd.,
Biztec Entrepreneurship Program,
F2 Venture Capital,
Biztec 2017,
Plus500™,
Student 7 | סטודנט 7,
Tay Tech Industries Ltd.
Fibreath's categories are Pharmaceutical Manufacturing
Fibreath's founding year is 2025
